STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
4D Molecular Therapeutics, Inc.
FDMT
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$0.00
-99.9%
Net Income/Share
$-2.98
-15.7%
Operating CF/Share
$-2.49
-28.8%
Free CF/Share
$-2.57
-27.8%
Cash/Share
$7.88
+6.9%
Book Value/Share
$9.47
+20.3%
Tangible Book/Share
$9.47
+20.3%
Equity/Share
$9.47
+20.3%
Interest Debt/Share
$0.46
+21.7%
Valuation
Market Cap
$300.47M
-62.1%
Enterprise Value
$175.74M
-68.5%
P/E Ratio
-1.87
+76.2%
P/S Ratio
8,120.72
+21127.4%
P/OCF Ratio
-2.23
+78.7%
P/FCF Ratio
-2.17
+78.5%
P/B Ratio
0.59
-77.2%
P/TB Ratio
0.59
-77.2%
EV/Sales
4,749.64
+17528.5%
EV/EBITDA
-0.97
+81.1%
Profitability
Earnings Yield
-53.54%
-320.9%
FCF Yield
-46.05%
-364.7%
ROE
-31.51%
+3.8%
ROIC
-34.99%
-0.5%
Return on Tangible Assets
-28.71%
+3.2%
Capital Allocation
CapEx/OCF
-2.81%
+23.1%
CapEx/Revenue
10232.43%
+76423.5%
CapEx/Depreciation
0.56
+17.1%
SBC/Revenue
70583.78%
+74281.3%
Balance Sheet
Debt/Equity
0.05
+1.1%
Debt/Assets
0.04
+1.7%
Net Debt/EBITDA
0.69
-68.1%
Current Ratio
14.92
-4.7%
Interest Coverage
0.00x
Income Quality
0.84
+11.3%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$6.95
+6.2%